Gisele Dion
DirectoratCytek Biosciences· In proxies 2023–2024
Gisele Dion sits on 2 public boards.
Boards1
- Inhibikase TherapeuticsDirector · 1 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Cytek BiosciencesPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -37%
- Inhibikase TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?